N-(4-Bromo-2-methyl-phenyl)-2-chloro-acetamide, 5mg

3-Chloro-5-methoxybenzaldehyde, 95.0%, 10g

2-(2-Aminoethylamino)ethanol, min. 98%, for synthesis, 2.5 L, glass packaging

6-Methyl-1H-indole-4-carboxylic acid, 95.0%, 25mg

(R)-5,5',6,6',7,7',8,8'-Octahydro[1,1'-binaphthalene]-2,2'-diol, 5g

2-(4-Nitro-phenoxy)-ethylamine, 95.0%, 1g

1-Boc-4-(Aminomethyl)-4-methylpiperidine, 95.0%, 5g

(1H-Pyrrolo[2,3-b]pyridin-5-yl)methanamine, 95.0%, 1g

Bis(2-isopropoxyethyl)amine>97.0%(GC)(T)5g

4-(4-hexylphenyl)-1,3-thiazol-2-amine, 98%, 250mg

4-[2-(4-chlorophenyl)acetyl]-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

4-bromo-[1,2,3]triazolo[1,5-a]pyridine, 98%, 250mg

tert-Butyl 2-Oxoazetidine-1-carboxylate, 97.0%, 100mg